Скачать или смотреть HIMS Stock Alert: Why It’s Crashing in 2026 & Should You Buy?

Hims & Hers Health (HIMS) stock is facing its most volatile period yet in early 2026. Following a massive 50% price drop and legal pressure from Novo Nordisk regarding compounded GLP-1 medications, investors are wondering if this is a "buy the dip" opportunity or a permanent breakdown of the business model. We analyze the DOJ referral, the impact of halting Wegovy copycats, and what to expect from the upcoming February 23rd earnings report.

Queries: Hims stock price today, HIMS stock analysis 2026, Hims & Hers weight loss drug update, HIMS vs Novo Nordisk lawsuit, why is HIMS stock falling, HIMS earnings prediction Feb 2026, best telehealth stocks to buy now, HIMS stock forecast, Hims cancer testing expansion.

00:00 HIMS Stock Market Crash & Novo Nordisk Lawsuit
01:45 DOJ Referral and Regulatory Risks Explained
03:15 Revenue Impact of Halting Compounded GLP-1s
05:10 New Cancer Testing Labs & Pivot Strategy
07:20 Earnings Preview (Feb 23) and Price Targets

#HIMS #HimsAndHers #StockMarket #Investing #Telehealth #WeightLossDrug #GrowthStocks #StockAlert